NEWS RELEASES 2023
Dec 20, 2023 - GHG Provides Corporate Update
Oct 16, 2023 - GHG Announces Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption
Oct 11, 2023 - GHG Executes LOI with B-Organic R&D Corp. to Create 50% Joint Venture Around its Patented Bioactive Lipid Agents Technology
Oct 3, 2023 - GHG Announces Ramsey Douglas Appointed to the Board of Directors
Sep 26, 2023 - GHG Announces Effective Date of Consolidation and Closing of Debenture Restructuring
Sep 19, 2023 - GHG Successfully Restructures Debt
Aug 18, 2023 - GHG Announces Closing of Debt Settlement
Aug 11, 2023 - GHG Announces Debt Settlement
Jul 31, 2023 - GHG Provides Update
May 11, 2023 - GHG Provides Update on Apollon Formularies Transaction
Apr 28, 2023 - GHG Concludes First U.S. Sublicense Related to its Recently Acquired Exclusive North American License of Apollon Formularies IP
Apr 26, 2023 - GHG Announces an Initiative to Produce Affordable, Carbon Negative, Hemp-Based Housing in Quebec
Apr 20, 2023 - GHG Announces Brokered Private Placement
Mar 31 2023 - Global Hemp Group Announces Closing of 1st tranche of PP
Mar 30, 2023 - Global Hemp Group Announces Jeff Nagel Joins Advisory Board as Product Manufacturing Advisor
Mar 21, 2023 - Global Hemp Group adds Israel, the European Union and Morocco as Exclusive Global Licenses from Apollon Formularies, PLC
Mar 20, 2023 - Global Hemp Group Announces Stephen D. Barnhill Jr. has been Appointed Interim President & CEO
Mar 8, 2023 - Global Hemp Group Announces Non-Brokered Private Placement
Feb 22, 2023 - Global Hemp Group Announces Cancellation of Options
Feb 17, 2023 - Global Hemp Group Welcomes Mathieu Couillard and the continuing engagement of Twilight Capital on its Advisory Board
Feb 14, 2023 - Global Hemp Group Announces the Appointment of Aurelio Useche and Veronique Laberge to the Company’s Board Of Directors
Feb 6, 2023 - Global Hemp Group Announces Completion
of Consulting Agreement with Dr. Stephen Barnhill
Jan 27, 2023 - MCTO
Jan 23, 2023 - Global Hemp Group Announces Execution of Exclusive Licensing Agreement for the Intellectual Property of Apollon Formularies
Jan 11, 2023 - Global Hemp Group Announces Execution of Binding LOI with Apollon Formularies Plc
Jan 4, 2023 - Global Hemp Group Provides Update
Jan 3, 2023 - Global Hemp Group Announces Termination of Revitalize Earth Transaction